These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26590643)

  • 1. Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.
    Hall IJ; Lee Smith J
    Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S483-8. PubMed ID: 26590643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.
    Hoffman RM
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):197-201. PubMed ID: 23271773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
    Wilt TJ
    Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence review of active surveillance in men with localized prostate cancer.
    Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
    Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
    Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
    Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.
    Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Stewart ST; Bhatnagar V; Sweeney CJ; Stahl JE; McMahon PM
    JAMA; 2010 Dec; 304(21):2373-80. PubMed ID: 21119084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
    Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
    Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.
    Hoffman RM; Lobo T; Van Den Eeden SK; Davis KM; Luta G; Leimpeter AD; Aaronson D; Penson DF; Taylor K
    Med Decis Making; 2019 Nov; 39(8):962-974. PubMed ID: 31631745
    [No Abstract]   [Full Text] [Related]  

  • 9. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.
    Myers RE; Leader AE; Censits JH; Trabulsi EJ; Keith SW; Petrich AM; Quinn AM; Den RB; Hurwitz MD; Lallas CD; Hegarty SE; Dicker AP; Zeigler-Johnson CM; Giri VN; Ayaz H; Gomella LG
    J Cancer Educ; 2018 Feb; 33(1):180-185. PubMed ID: 27418065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.
    Donovan JL
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):191-6. PubMed ID: 23271772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
    Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
    BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy.
    Roussel B; Ouellet GM; Mohile SG; Dale W
    Clin Geriatr Med; 2015 Nov; 31(4):615-29. PubMed ID: 26476120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
    Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.
    Kim SP; Knight SJ; Tomori C; Colella KM; Schoor RA; Shih L; Kuzel TM; Nadler RB; Bennett CL
    Cancer Invest; 2001; 19(7):684-91. PubMed ID: 11577809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-Based Assessment of Determining Treatments for Prostate Cancer.
    Chamie K; Williams SB; Hu JC
    JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
    Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
    JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.
    Makarov DV; Feuer Z; Ciprut S; Lopez NM; Fagerlin A; Shedlin M; Gold HT; Li H; Lynch G; Warren R; Ubel P; Ravenell JE
    Trials; 2021 Feb; 22(1):128. PubMed ID: 33568208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.